Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

57.56 +1.06 (+1.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Friday's pre-market session: top gainers and losers in the S&P500 index
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session. 
Via Chartmill
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political US Equities
How Is The Market Feeling About Hologic?
Via Benzinga
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
From Hologic, Inc.
Via Business Wire
Peering Into Hologic's Recent Short Interest
Via Benzinga
Expert Ratings For Hologic
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
FDA Warns Hologic Over BioZorb Manufacturing Violations
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted 
Via Benzinga
Exposures Product Safety
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
From Hologic, Inc.
Via Business Wire
Looking Into Hologic's Recent Short Interest
Via Benzinga
Assessing Hologic: Insights From 10 Financial Analysts
Via Benzinga
Hologic Completes Acquisition of Gynesonics, Inc.
From Hologic, Inc.
Via Business Wire
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
From Hologic, Inc.
Via Business Wire
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
From Hologic, Inc.
Via Business Wire
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Via Benzinga
This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Martin Madaus Elected to Hologic Board of Directors
From Hologic, Inc.
Via Business Wire
New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence
From Hologic, Inc.
Via Business Wire
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
From Hologic, Inc.
Via Business Wire
Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally... 
Via Benzinga
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
From Hologic, Inc.
Via Business Wire
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.